Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.94 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Change in Other Operating Assets (2025 - 2026)

Updated

Analysis

Polaryx Therapeutics (PLYX) Change in Other Operating Assets (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -122.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 188.00 Mn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 13.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Polaryx Therapeutics 91.49 Mn 67.10 Mn - -152,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -152,000.00
Mar 31, 2026 395,000.00
Jun 30, 2025 70,000.00
Mar 31, 2025 4,000.00
API Access

Polaryx Therapeutics Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=PLYX&period=max&api_key=YOUR_API_KEY